(Q40011550)

English

Loss of interferon-gamma inducibility of the MHC class II antigen processing pathway in head and neck cancer: evidence for post-transcriptional as well as epigenetic regulation

scientific article published on 16 February 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Loss of interferon-gamma inducibility of the MHC class II antigen processing pathway in head and neck cancer: evidence for post-transcriptional as well as epigenetic regulation (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

head and neck cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

head and neck carcinoma

1 reference

based on heuristic

inferred from title

Barbara Seliger

object named as

B Seliger

7

0 references

author name string

M Meissner

1

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

T L Whiteside

2

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

P van Kuik-Romein

3

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

E M Valesky

4

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

P J van den Elsen

5

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

R Kaufmann

6

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

language of work or name

0 references

publication date

16 February 2008

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

British Journal of Dermatology

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

158

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

930-940

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

The central role of CD4(+) T cells in the antitumor immune response

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08465.X

21 January 2018

MHC class II molecules in tumour immunology: prognostic marker and target for immune modulation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08465.X

21 January 2018

CD4 T cells in tumor immunity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08465.X

21 January 2018

Differential expression of MHC class II molecules in highly metastatic breast cancer cells is mediated by the regulation of the CIITA transcription Implication of CIITA in tumor and metastasis development

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08465.X

21 January 2018

CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a Th1 polarization of the tumor microenvironment, tumor rejection, and specific antitumor memory.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08465.X

21 January 2018

MHC class II-transfected tumor cells induce long-term tumor-specific immunity in autologous mice.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08465.X

21 January 2018

Strong HLA-DR expression in large bowel carcinomas is associated with good prognosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08465.X

21 January 2018

Analysis of HLA-DR expression on keratinocytes in cervical neoplasia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08465.X

21 January 2018

Lymphocyte subset infiltration patterns and HLA antigen status in colorectal carcinomas and adenomas

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08465.X

21 January 2018

HLA-DR antigen expression in colorectal carcinomas: influence of expression by IFN-gamma in situ and its association with tumour progression

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08465.X

21 January 2018

The bare lymphocyte syndrome and the regulation of MHC expression

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08465.X

21 January 2018

Immunotherapy with effector cells and IL-2 of lymph node metastases of human squamous-cell carcinoma of the head and neck established in nude mice

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08465.X

21 January 2018

Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08465.X

21 January 2018

Selective abrogation of major histocompatibility complex class II expression on extrahematopoietic cells in mice lacking promoter IV of the class II transactivator gene.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08465.X

21 January 2018

Defective MHC class II expression in an MHC class II deficiency patient is caused by a novel deletion of a splice donor site in the MHC class II transactivator gene

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08465.X

21 January 2018

Lack of CIITA expression is central to the absence of antigen presentation functions of trophoblast cells and is caused by methylation of the IFN-gamma inducible promoter (PIV) of CIITA.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08465.X

21 January 2018

Lack of class II transactivator causes severe deficiency of HLA-DR expression in small cell lung cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08465.X

21 January 2018

MHC class II-deficient tumor cell lines with a defective expression of the class II transactivator

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08465.X

21 January 2018

Lack of IFN-gamma-mediated induction of the class II transactivator (CIITA) through promoter methylation is predominantly found in developmental tumor cell lines

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08465.X

21 January 2018

Complicated mechanisms of class II transactivator transcription deficiency in small cell lung cancer and neuroblastoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08465.X

21 January 2018

Epigenetic silencing of the CIITA gene and posttranscriptional regulation of class II MHC genes in ocular melanoma cells.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08465.X

21 January 2018

Defects in the human leukocyte antigen class I antigen processing machinery in head and neck squamous cell carcinoma: association with clinical outcome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08465.X

21 January 2018

Simplified mammalian DNA isolation procedure

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08465.X

21 January 2018

Major histocompatibility complex class II-transfected tumor cells present endogenous antigen and are potent inducers of tumor-specific immunity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08465.X

21 January 2018

Patterns of constitutive and IFN-gamma inducible expression of HLA class II molecules in human melanoma cell lines.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08465.X

21 January 2018

Different levels of control prevent interferon-gamma-inducible HLA-class II expression in human neuroblastoma cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08465.X

21 January 2018

Inactivation of class II transactivator by DNA methylation and histone deacetylation associated with absence of HLA-DR induction by interferon-gamma in haematopoietic tumour cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08465.X

21 January 2018

Epigenetic inactivation of class II transactivator (CIITA) is associated with the absence of interferon-gamma-induced HLA-DR expression in colorectal and gastric cancer cells.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08465.X

21 January 2018

DNA methylation and expression of major histocompatibility complex class I and class II transactivator genes in human developmental tumor cells and in T cell malignancies.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08465.X

21 January 2018

Regulation of HLA class II gene expression: the case for posttranscriptional control levels

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08465.X

21 January 2018

Methylation of class II trans-activator promoter IV: a novel mechanism of MHC class II gene control

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08465.X

21 January 2018

DNA hypermethylation is a mechanism for loss of expression of the HLA class I genes in human esophageal squamous cell carcinomas

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08465.X

21 January 2018

Histone deacetylation, but not hypermethylation, modifies class II transactivator and MHC class II gene expression in squamous cell carcinomas

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2008.08465.X

21 January 2018

Identifiers

10.1111/J.1365-2133.2008.08465.X

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40011550&oldid=1882621689"